Erlotinib in a once-daily high-dose oral regimen could mitigate Chikungunya virus titer in mice

Chidinma Nelson Orji, Naphat Loeanurit, Akeanan Sroithongmoon, Noppadol Wacharachaisurapol, Yaowatree Jumroen, Wanna Eiamart, Supeecha Wittayalertpanya, Weerachai Chaijamorn, Tatta Sriboonruang, Jirapat Vamananda, Tanatorn Khotavivattana, Siwaporn Boonyasuppayakorn

Open source

DOI: 10.1371/journal.pone.0360169
Published: 2026-11-02
Container: PLOS One
Publisher: Public Library of Science (PLoS)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1371/journal.pone.0360169,
  title = {Erlotinib in a once-daily high-dose oral regimen could mitigate Chikungunya virus titer in mice},
  author = {Chidinma Nelson Orji and Naphat Loeanurit and Akeanan Sroithongmoon and Noppadol Wacharachaisurapol and Yaowatree Jumroen and Wanna Eiamart and Supeecha Wittayalertpanya and Weerachai Chaijamorn and Tatta Sriboonruang and Jirapat Vamananda and Tanatorn Khotavivattana and Siwaporn Boonyasuppayakorn},
  year = {2026},
  journal = {PLOS One},
  doi = {10.1371/journal.pone.0360169},
  url = {https://doi.org/10.1371/journal.pone.0360169}
}

RIS

TY  - JOUR
TI  - Erlotinib in a once-daily high-dose oral regimen could mitigate Chikungunya virus titer in mice
AU  - Chidinma Nelson Orji
AU  - Naphat Loeanurit
AU  - Akeanan Sroithongmoon
AU  - Noppadol Wacharachaisurapol
AU  - Yaowatree Jumroen
AU  - Wanna Eiamart
AU  - Supeecha Wittayalertpanya
AU  - Weerachai Chaijamorn
AU  - Tatta Sriboonruang
AU  - Jirapat Vamananda
AU  - Tanatorn Khotavivattana
AU  - Siwaporn Boonyasuppayakorn
PY  - 2026
JO  - PLOS One
DO  - 10.1371/journal.pone.0360169
UR  - https://doi.org/10.1371/journal.pone.0360169
ER  -

APA

Orji, C. N., Loeanurit, N., Sroithongmoon, A., Wacharachaisurapol, N., Jumroen, Y., Eiamart, W., Wittayalertpanya, S., Chaijamorn, W., Sriboonruang, T., Vamananda, J., Khotavivattana, T., & Boonyasuppayakorn, S. (2026). Erlotinib in a once-daily high-dose oral regimen could mitigate Chikungunya virus titer in mice. PLOS One. https://doi.org/10.1371/journal.pone.0360169

Source records

crossref · retrieved 2026-11-04T16:40:17.583Z